✦ LIBER ✦

Selection of patients with malignant ascites for a peritoneovenous shunt

✍ Scribed by Dominic K. Cheung; John H. Raaf

Publisher: John Wiley and Sons
Year: 1982
Tongue: English
Weight: 459 KB
Volume: 50
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19820915)50:6<1204::aid-cncr2820500631>3.0.co;2-w

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Peritoneovenous shunt for palliation of

Peritoneovenous shunt for palliation of malignant ascites

✍ Raman Qazi; Edwin D. Savlov 📂 Article 📅 1982 🏛 John Wiley and Sons 🌐 English ⚖ 231 KB 👁 1 views

Peritoneovenous shunt for intractable ma

Peritoneovenous shunt for intractable malignant ascites. A single case report of metastatic peritoneal mesothelioma implanted via leveen shunt

✍ Harry E. Nervino; Fred C. Gebhardt 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 English ⚖ 378 KB 👁 1 views

Inguinal hernia repair in patients with

Inguinal hernia repair in patients with peritoneovenous shunt: Risk of air embolism

✍ Dr D. Gui; G. Giangiuliani; A. Veneziani; G. Giorgi; G. Sganga 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 English ⚖ 116 KB 👁 1 views

Efficacy of postacute brain injury rehab

Efficacy of postacute brain injury rehabilitation for patients with primary malignant brain tumors

✍ Mark Sherer; Christina A. Meyers; Paula Bergloff 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 120 KB 👁 2 views

## Background: Patients with primary malignant brain tumors (pmbt) often have neurobehavioral deficits due to the tumor, subsequent surgery, and therapies that interfere with their ability to live independently or work. previous studies have shown that such patients generally have a progressive dec

Tolerance of chemotherapy following sple

Tolerance of chemotherapy following splenectomy for leukopenia or thrombocytopenia in patients with malignant lymphomas

✍ Boyd A. Nies; William P. Creger 📂 Article 📅 1967 🏛 John Wiley and Sons 🌐 English ⚖ 364 KB 👁 1 views

A phase II study of gemcitabine in patie

A phase II study of gemcitabine in patients with malignant pleural mesothelioma

✍ Jan P. van Meerbeeck; Paul Baas; Channa Debruyne; Harry J. Groen; Chris Manegold 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 115 KB 👁 2 views

## BACKGROUND. Gemcitabine has shown activity in patients with less chemosensitive solid tumors. Phase II screening of novel drugs is an accepted method with which to investigate new therapies in malignant mesothelioma. The European Organization for Research and Treatment of Cancer-Lung Cancer Coo